Stock listing
NASDAQ:AARD Aardvark Therapeutics, Inc. Stock
Home listing (NASDAQ) of Aardvark Therapeutics, Inc.
Follow Aardvark Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:AARD
$0.923 USD -0.077 (-7.7%)
Close on Nov 20, 2026
- Day range
- $0.900 – $1.060 USDNov 20, 2026
- Volume
- 241,067 sharesNov 20, 2026
- Market cap
- $20.20M USDAt the close on Nov 20, 2026 · price × 21.89M shares outstanding
- 52-week range
- $0.900 – $16.600 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $1.23M USDMedian day 191,550 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:AARD · Home | $0.923 USD | -0.077 (-7.7%) | 241,067 | $1.000 | $1.060 | $0.900 | $1.000 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:AARD · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.923 | -0.077 | -7.7% | $1.000 | $1.060 | $0.900 | 241,067 | |
| $1.000 | +0.090 | +9.9% | $0.960 | $1.100 | $0.950 | 486,486 | |
| $0.910 | -0.240 | -20.9% | $1.160 | $1.210 | $0.906 | 530,041 | |
| $1.150 | -0.110 | -8.7% | $1.240 | $1.380 | $1.100 | 475,501 | |
| $1.260 | -0.070 | -5.3% | $1.330 | $1.480 | $1.210 | 215,221 | |
| $1.330 | -0.190 | -12.5% | $1.580 | $1.700 | $1.310 | 402,400 | |
| $1.520 | -0.070 | -4.4% | $1.580 | $1.615 | $1.510 | 249,800 | |
| $1.590 | +0.220 | +16.1% | $1.350 | $1.680 | $1.340 | 387,500 | |
| $1.370 | +0.020 | +1.5% | $1.320 | $1.440 | $1.290 | 242,600 | |
| $1.350 | +0.180 | +15.4% | $1.210 | $1.420 | $1.171 | 682,800 | |
| $1.170 | +0.060 | +5.4% | $1.100 | $1.180 | $1.090 | 221,700 | |
| $1.110 | -0.150 | -11.9% | $1.180 | $1.231 | $1.095 | 374,600 | |
| $1.260 | +0.030 | +2.4% | $1.250 | $1.280 | $1.169 | 216,200 | |
| $1.230 | +0.030 | +2.5% | $1.220 | $1.290 | $1.210 | 263,400 | |
| $1.200 | -0.160 | -11.8% | $1.370 | $1.396 | $1.200 | 339,200 | |
| $1.360 | -0.080 | -5.6% | $1.390 | $1.460 | $1.330 | 463,800 | |
| $1.440 | -0.070 | -4.6% | $1.480 | $1.530 | $1.362 | 955,900 | |
| $1.510 | +0.210 | +16.2% | $1.220 | $1.590 | $1.176 | 2,019,000 | |
| $1.300 | +0.220 | +20.4% | $1.090 | $1.390 | $1.090 | 4,282,800 | |
| $1.080 | -0.310 | -22.3% | $1.245 | $1.390 | $0.930 | 4,957,700 | |
| $1.390 | -2.560 | -64.8% | $2.990 | $3.000 | $1.390 | 16,346,500 | |
| $3.950 | -0.460 | -10.4% | $4.270 | $4.310 | $3.890 | 1,415,300 | |
| $4.410 | +0.510 | +13.1% | $3.950 | $4.540 | $3.950 | 218,400 | |
| $3.900 | +0.160 | +4.3% | $3.800 | $4.051 | $3.780 | 66,700 | |
| $3.740 | -0.040 | -1.1% | $3.750 | $4.050 | $3.640 | 129,800 | |
| $3.780 | -0.080 | -2.1% | $4.190 | $4.190 | $3.730 | 97,200 | |
| $3.860 | -0.020 | -0.5% | $3.860 | $3.977 | $3.770 | 68,800 | |
| $3.880 | -0.160 | -4.0% | $3.930 | $4.350 | $3.830 | 126,100 | |
| $4.040 | -0.410 | -9.2% | $4.440 | $4.630 | $4.030 | 218,300 | |
| $4.450 | -0.310 | -6.5% | $4.810 | $4.877 | $4.400 | 99,900 | |
| $4.760 | +0.050 | +1.1% | $4.610 | $4.820 | $4.600 | 140,900 | |
| $4.710 | -0.250 | -5.0% | $4.770 | $5.090 | $4.570 | 316,000 | |
| $4.960 | -0.080 | -1.6% | $4.950 | $5.330 | $4.690 | 212,000 | |
| $5.040 | -0.180 | -3.4% | $5.280 | $5.450 | $4.660 | 251,900 | |
| $5.220 | +0.230 | +4.6% | $5.030 | $5.370 | $5.030 | 61,300 | |
| $4.990 | -0.280 | -5.3% | $5.370 | $5.660 | $4.880 | 147,700 | |
| $5.270 | 0.000 | 0.0% | $5.290 | $5.420 | $5.130 | 47,800 | |
| $5.270 | -0.080 | -1.5% | $5.420 | $5.524 | $5.270 | 28,100 | |
| $5.350 | +0.080 | +1.5% | $5.210 | $5.390 | $5.002 | 39,600 | |
| $5.270 | +0.210 | +4.2% | $5.050 | $5.320 | $4.960 | 60,600 | |
| $5.060 | -0.490 | -8.8% | $5.570 | $5.600 | $5.020 | 71,500 | |
| $5.550 | -0.010 | -0.2% | $5.550 | $5.690 | $5.325 | 96,100 | |
| $5.560 | -0.190 | -3.3% | $5.740 | $5.740 | $5.415 | 54,800 | |
| $5.750 | +0.180 | +3.2% | $5.510 | $5.840 | $5.500 | 101,300 | |
| $5.570 | +0.190 | +3.5% | $5.440 | $5.575 | $5.340 | 110,300 | |
| $5.380 | -0.150 | -2.7% | $5.440 | $5.590 | $5.190 | 129,800 | |
| $5.530 | +0.380 | +7.4% | $5.320 | $5.770 | $5.190 | 258,100 | |
| $5.150 | +0.130 | +2.6% | $5.040 | $5.290 | $4.930 | 47,900 | |
| $5.020 | -0.530 | -9.5% | $5.470 | $5.545 | $5.010 | 64,200 | |
| $5.550 | +0.420 | +8.2% | $4.900 | $5.880 | $4.800 | 216,900 | |
| $5.130 | +0.120 | +2.4% | $5.110 | $5.540 | $4.975 | 276,600 | |
| $5.010 | +0.090 | +1.8% | $4.870 | $5.015 | $4.540 | 209,400 | |
| $4.920 | -0.410 | -7.7% | $5.330 | $5.456 | $4.895 | 109,700 | |
| $5.330 | -0.050 | -0.9% | $5.330 | $5.710 | $5.100 | 164,700 | |
| $5.380 | -0.350 | -6.1% | $5.720 | $5.991 | $5.150 | 257,800 | |
| $5.730 | -0.220 | -3.7% | $5.920 | $6.190 | $5.600 | 89,300 | |
| $5.950 | +0.030 | +0.5% | $6.050 | $6.225 | $5.795 | 59,400 | |
| $5.920 | -0.180 | -3.0% | $6.000 | $6.245 | $5.807 | 85,000 | |
| $6.100 | +0.310 | +5.4% | $5.700 | $6.155 | $5.300 | 125,400 | |
| $5.790 | -0.830 | -12.5% | $6.470 | $6.470 | $5.620 | 143,000 | |
| $6.620 | -0.190 | -2.8% | $6.890 | $7.085 | $6.585 | 74,200 | |
| $6.810 | -0.440 | -6.1% | $7.290 | $7.300 | $6.210 | 111,900 | |
| $7.250 | +0.370 | +5.4% | $6.940 | $7.310 | $6.490 | 145,204 | |
| $6.880 | +0.060 | +0.9% | $6.750 | $6.970 | $6.283 | 83,299 | |
| $6.820 | +0.930 | +15.8% | $5.910 | $6.900 | $5.800 | 173,700 | |
| $5.890 | -0.860 | -12.7% | $6.760 | $7.120 | $5.760 | 250,200 |
- Ticker
- NASDAQ:AARD
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 13, 2026
Aardvark Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates
Latest deck · Oct 23, 2026
Technical Presentation (October 2026)
Technical · 26 slides
Latest news
Aardvark Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates
Nov 13, 2026
Closed $1.33 (-12.5%) on Nov 13, 2026
Aardvark Therapeutics Reports Exploratory Data from the Terminated HERO and Open-Label Extension Trials
Oct 23, 2026
Closed $1.39 (-64.8%) on Oct 23, 2026
Aardvark Therapeutics Announces FDA Has Lifted the Clinical Hold on ARD-101 for the Treatment of Prader-Willi Syndrome and Will Host Webcast to Review the Available Exploratory Phase 3 HERO/OLE Data
Oct 22, 2026
Closed $1.39 (-64.8%) on Oct 23, 2026
Aardvark Therapeutics Appoints Clinical Development Leader David Zhang, Ph.D., MBA, to its Board of Directors
Oct 8, 2026
Closed $4.71 (-5.0%) on Oct 8, 2026
Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Oct 2, 2026
Closed $5.22 (+4.6%) on Oct 5, 2026
Aardvark Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
Aug 11, 2026
Closed $6.57 (-8.6%) on Aug 12, 2026
Aardvark Therapeutics Plans to Unblind HERO and OLE Data to Inform Path Forward Following FDA Clinical Hold
May 14, 2026
Closed $4.57 (-32.1%) on May 15, 2026
Aardvark Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
May 7, 2026
Closed $5.60 (-4.9%) on May 7, 2026
Aardvark Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Mar 23, 2026
Closed $4.07 (-0.1%) on Mar 23, 2026
Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome
Feb 27, 2026
Closed $5.47 (-56.2%) on Mar 2, 2026
Decks
Technical Presentation (October 2026)
Technical · 26 slides · Oct 23, 2026
Investor Presentation (January 2026)
Investor deck · 29 slides · Jan 12, 2026
ObesityWeek Investor Webinar 2025
Conference · 65 slides · Nov 6, 2025
Investor Presentation (September 2025)
Investor deck · 22 slides · Sep 3, 2025
Aardvark Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 16 in the last 12 months · 33 in all · newest Nov 13, 2026 · oldest 2025
- Decks
- 4 decks · latest Oct 23, 2026
Where Aardvark Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:AARD · Home listing · This page | NASDAQ | United States | USD |
| BOATS:AARD | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Aardvark Therapeutics, Inc.